(Q37264559)

19 August 2017

1 reference

title

Genetic factors that confer sensitivity to HAART in HIV-infected subjects: implication of a benefit of an earlier initiation of HAART. (English)

1 reference

19 August 2017

Toshiaki Nakajima

1

1 reference

19 August 2017

Akinori Kimura

series ordinal

2

1 reference

19 August 2017

publication date

1 September 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

9

1 reference

19 August 2017

issue

9

1 reference

19 August 2017

page(s)

1347-1351

1 reference

CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1347

HLA-Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1347

Treatment history and baseline viral load, but not viral tropism or CCR-5 genotype, influence prolonged antiviral efficacy of highly active antiretroviral treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1347

Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1347

Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1347

Genetics of resistance to HIV infection: Role of co-receptors and co-receptor ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1347

Human genes that limit AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1347

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1347

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1347

The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1347

Copy number variations of CCL3L1 and long-term prognosis of HIV-1 infection in asymptomatic HIV-infected Japanese with hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1347

Influence of host genetic variation on susceptibility to HIV type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1347

Genetic variations in HLA-B region and hypersensitivity reactions to abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1347

HLA-B*5701 screening for hypersensitivity to abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1347

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1347

A whole-genome association study of major determinants for host control of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1347

CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1347

Host CCL3L1 gene copy number in relation to HIV-1-specific CD4+ and CD8+ T-cell responses and viral load in South African women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1347

Effects of Human Leukocyte Antigen Class I Genetic Parameters on Clinical Outcomes and Survival after Initiation of Highly Active Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1347

10.2217/14622416.9.9.1347

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference